During the past decade, Sutter Solano Medical Center/Cancer Center conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 71 clinical trials were completed, i.e. on average, 98.6% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 40 clinical trials were completed. i.e. 235.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Solano Medical Center/Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 79 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "NRG Oncology" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Solano Medical Center/Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Solano Medical Center/Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Breast Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (7 trials). Many other conditions were trialed in "Sutter Solano Medical Center/Cancer Center" in a lesser frequency.

Most popular intervention types in "Sutter Solano Medical Center/Cancer Center" are "Drug" (123 trials), "Other" (102 trials), "Biological" (66 trials), "Procedure" (32 trials) and "Radiation" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (65 trials), "Quality-of-Life Assessment" (36 trials), "Bevacizumab" (22 trials), "Paclitaxel" (20 trials) and "Computed Tomography" (18 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Solano Medical Center/Cancer Center" are 113 trials for "All" genders, 30 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Sutter Solano Medical Center/Cancer Center". undefined are not yet recruiting, 31 are recruiting, 73 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Sutter Solano Medical Center/Cancer Center, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Solano Medical Center/Cancer Center, 2 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".